tiprankstipranks
Inoviq Ltd (AU:IIQ)
:IIQ

Inoviq Ltd (IIQ) Price & Analysis

Compare
1 Followers

IIQ Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

6.10%93.90%
Mutual Funds
― Other Institutional Investors
93.90% Public Companies and
Individual Investors

IIQ FAQ

What was Inoviq Ltd’s price range in the past 12 months?
Inoviq Ltd lowest share price was AU$0.34 and its highest was AU$0.80 in the past 12 months.
    What is Inoviq Ltd’s market cap?
    Inoviq Ltd’s market cap is AU$45.17M.
      When is Inoviq Ltd’s upcoming earnings report date?
      Inoviq Ltd’s upcoming earnings report date is Sep 02, 2025 which is in 154 days.
        How were Inoviq Ltd’s earnings last quarter?
        Inoviq Ltd released its earnings results on Feb 20, 2025. The company reported -AU$0.033 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.033.
          Is Inoviq Ltd overvalued?
          According to Wall Street analysts Inoviq Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Inoviq Ltd pay dividends?
            Inoviq Ltd does not currently pay dividends.
            What is Inoviq Ltd’s EPS estimate?
            Inoviq Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Inoviq Ltd have?
            Inoviq Ltd has 111,526,700 shares outstanding.
              What happened to Inoviq Ltd’s price movement after its last earnings report?
              Inoviq Ltd reported an EPS of -AU$0.033 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Inoviq Ltd?
                Currently, no hedge funds are holding shares in AU:IIQ
                ---

                Company Description

                Inoviq Ltd

                INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Biotron Limited
                Imugene Limited
                Patrys Limited
                Proteomics International Laboratories Ltd.
                Recce Pharmaceuticals Ltd.
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis